Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04169841
Title Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment (GUIDE2REPAIR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Georges Francois Leclerc
Indications

endometrial cancer

clear cell renal cell carcinoma

ovarian cancer

lung cancer

breast cancer

prostate cancer

head and neck cancer

transitional cell carcinoma

Therapies

Durvalumab + Olaparib + Tremelimumab

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST